HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.

AuthorsLieke S Kamphuis, Wai-Kwan Lam-Tse, Willem A Dik, Paul L van Daele, Paula van Biezen, Dik J Kwekkeboom, Robert W Kuijpers, Herbert Hooijkaas, Jan A van Laar, Jeroen Bastiaans, G Seerp Baarsma, P Martin van Hagen
JournalAmerican journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 184 Issue 10 Pg. 1214-6 (Nov 15 2011) ISSN: 1535-4970 [Electronic] United States
PMID22086995 (Publication Type: Clinical Trial, Letter)
Chemical References
  • Antibodies, Monoclonal, Humanized
  • Tumor Necrosis Factor-alpha
  • Adalimumab
Topics
  • Adalimumab
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Humans
  • Sarcoidosis, Pulmonary (diagnostic imaging, drug therapy)
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: